Publications

2016

Pes L, Kim Y, Tung C-. Development of a fluorescent cardiomyocyte specific binding probe. Bioorg Med Chem. 2016;24(8):1706-17.

2015

Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement. 2015;11(1):58-69.
Cooper MA, Nguyen TD, Xu B, Prince MR, Elad M, Wang Y, et al. Patch based reconstruction of undersampled data (PROUD) for high signal-to-noise ratio and high frame rate contrast enhanced liver imaging. Magn Reson Med. 2015;74(6):1587-97.
Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. Brain. 2015;138(Pt 9):2701-15.
Murakami Y, Kakeda S, Watanabe K, Ueda I, Ogasawara A, Moriya J, et al. Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease. AJNR Am J Neuroradiol. 2015;36(6):1102-8.
Simon KA, Warren NJ, Mosadegh B, Mohammady MR, Whitesides GM, Armes SP. Disulfide-Based Diblock Copolymer Worm Gels: A Wholly-Synthetic Thermoreversible 3D Matrix for Sheet-Based Cultures. Biomacromolecules. 2015;16(12):3952-8.
Deh K, Nguyen TD, Eskreis-Winkler S, Prince MR, Spincemaille P, Gauthier S, et al. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors. J Magn Reson Imaging. 2015;42(6):1592-600.
Abdallah CG, Jackowski A, Sato JR, Mao X, Kang G, Cheema R, et al. Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder. Eur Neuropsychopharmacol. 2015;25(8):1082-90.
Kuceyeski AF, Vargas W, Dayan M, Monohan E, Blackwell C, Raj A, et al. Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis. AJNR Am J Neuroradiol. 2015;36(4):702-9.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065